EP3024467A4 - Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe - Google Patents

Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe Download PDF

Info

Publication number
EP3024467A4
EP3024467A4 EP14828920.0A EP14828920A EP3024467A4 EP 3024467 A4 EP3024467 A4 EP 3024467A4 EP 14828920 A EP14828920 A EP 14828920A EP 3024467 A4 EP3024467 A4 EP 3024467A4
Authority
EP
European Patent Office
Prior art keywords
upregulating
hippocampus
compositions
memory
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14828920.0A
Other languages
German (de)
English (en)
Other versions
EP3024467A2 (fr
Inventor
Richard L. Watson
Anthony B. Wood
Gregory J. Archambeau
Supurna GHOSH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microdiffusion Inc
Original Assignee
Microdiffusion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdiffusion Inc filed Critical Microdiffusion Inc
Publication of EP3024467A2 publication Critical patent/EP3024467A2/fr
Publication of EP3024467A4 publication Critical patent/EP3024467A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP14828920.0A 2013-07-23 2014-07-23 Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe Withdrawn EP3024467A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361857306P 2013-07-23 2013-07-23
US201361888420P 2013-10-08 2013-10-08
US201461930388P 2014-01-22 2014-01-22
PCT/US2014/047892 WO2015013451A2 (fr) 2013-07-23 2014-07-23 Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe

Publications (2)

Publication Number Publication Date
EP3024467A2 EP3024467A2 (fr) 2016-06-01
EP3024467A4 true EP3024467A4 (fr) 2017-03-01

Family

ID=52393973

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14828920.0A Withdrawn EP3024467A4 (fr) 2013-07-23 2014-07-23 Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe

Country Status (6)

Country Link
US (1) US20150050344A1 (fr)
EP (1) EP3024467A4 (fr)
JP (1) JP2016532683A (fr)
AU (1) AU2014293138A1 (fr)
CA (1) CA2917958A1 (fr)
WO (1) WO2015013451A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6977979B2 (ja) * 2015-06-09 2021-12-08 国立大学法人大阪大学 神経損傷治療又は予防用医薬
CN109253994B (zh) 2018-10-31 2021-05-28 中国石油天然气股份有限公司 一种油气源汞同位素检测方法及装置
CN109253996B (zh) * 2018-10-31 2021-05-28 中国石油天然气股份有限公司 一种原油的汞同位素测试方法及其装置
CN109253995B (zh) 2018-10-31 2021-06-01 中国石油天然气股份有限公司 一种天然气的汞同位素测试方法及其装置
CN111618311B (zh) * 2019-02-28 2022-03-29 中国科学院化学研究所 一种银纳米颗粒分散液及其制备方法与应用
WO2024091523A1 (fr) * 2022-10-24 2024-05-02 2A Biosciences, Inc. Analogues de phényléthylamine à conformation restreinte
WO2024178425A1 (fr) * 2023-02-24 2024-08-29 2A Biosciences, Inc. Tryptamines hydroxyalkylées et méthoxyalkylées

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100028441A1 (en) * 2008-04-28 2010-02-04 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US20120039958A1 (en) * 2010-08-12 2012-02-16 Revalesio Corporation Compositions and methods for treatment of taupathy
US20120263764A1 (en) * 2011-04-13 2012-10-18 Revalesio Corporation Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2445743A1 (fr) * 2003-10-08 2005-04-08 The University Of British Columbia Methodes pour moduler les reponses neuronales
US20100310609A1 (en) * 2007-10-25 2010-12-09 Revalesio Corporation Compositions and methods for treatment of neurodegenerative diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100028441A1 (en) * 2008-04-28 2010-02-04 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US20120039958A1 (en) * 2010-08-12 2012-02-16 Revalesio Corporation Compositions and methods for treatment of taupathy
US20120263764A1 (en) * 2011-04-13 2012-10-18 Revalesio Corporation Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease

Also Published As

Publication number Publication date
WO2015013451A2 (fr) 2015-01-29
EP3024467A2 (fr) 2016-06-01
JP2016532683A (ja) 2016-10-20
AU2014293138A1 (en) 2016-02-25
WO2015013451A3 (fr) 2015-03-26
US20150050344A1 (en) 2015-02-19
CA2917958A1 (fr) 2015-01-29

Similar Documents

Publication Publication Date Title
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
EP2992097A4 (fr) Compositions et procédés
EP2951283A4 (fr) Compositions et procédés
EP3057586A4 (fr) Inhibiteurs de bromodomaine
EP3071205A4 (fr) Compositions de benzopipérazine en tant qu'inhibiteurs de bromodomaines bet
EP3004354A4 (fr) Compositions et procédés permettant de moduler l'expression de foxp3
EP3060561A4 (fr) Formulations de strigolactone et leurs utilisations
EP3014554A4 (fr) Panneau de recherche dynamique
EP3024467A4 (fr) Compositions et méthodes de régulation à la hausse de la plasticité de l'hippocampe et de l'apprentissage et de la mémoire dépendant de l'hippocampe
EP3080132A4 (fr) Inhibiteurs de bromodomaine
EP2974428B8 (fr) Procédés et systèmes d'arbitrage de spectre dynamique
EP3024428A4 (fr) Compositions et procédés pour minéralisation dentaire
EP3048146A4 (fr) Composition filmogène et procédé filmogène l'utilisant
EP2981320A4 (fr) Système de sommeil réparateur
EP2990039A4 (fr) Composition pharmaceutique solide
EP3087987A4 (fr) Composition pharmaceutique contenant du palonosétron
EP3048108A4 (fr) Dérivé thiénopipéridine et son utilisation
EP3140313A4 (fr) Microbiote du syndrome du côlon irritable et utilisations associées
EP3008731A4 (fr) Dispositifs de mémoire et procédés de fonctionnement de mémoire
EP3057441A4 (fr) Composition empêchant l'entérite nécrotique chez le galloanserans
EP3049389A4 (fr) Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques et procédés d'utilisation de ceux-ci
EP3037097A4 (fr) Polyrotaxane et composition médicale
EP3003324A4 (fr) Compositions pharmaceutiques
EP3090746A4 (fr) Composition pharmaceutique ne contenant pas d'antioxydant et son procédé de préparation
IL238851A0 (en) The history of pyrrolidine, pharmaceutical preparations and their uses

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160118

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170131

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/00 20060101AFI20170125BHEP

Ipc: A61K 31/58 20060101ALI20170125BHEP

Ipc: A61K 9/00 20060101ALI20170125BHEP

Ipc: A61P 25/28 20060101ALI20170125BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20170317